Retinoblastoma.

Carlos Rodriguez-Galindo, Darren B Orbach, Deborah VanderVeen

Journal: Pediatric clinics of North America 2015;62(1):201-23

PMID: 25435120

Full Text on Elsevier Science View on PubMed

Abstract

Retinoblastoma is the most common neoplasm of the eye in childhood, and represents 3% of all childhood malignancies. Retinoblastoma is a cancer of the very young; two-thirds are diagnosed before 2 years of age and 95% before 5 years. Retinoblastoma presents in 2 distinct clinical forms: (1) a bilateral or multifocal, heritable form (25% of all cases), characterized by the presence of germline mutations of the RB1 gene; and (2) a unilateral or unifocal form (75% of all cases), 90% of which are nonhereditary. The treatment of retinoblastoma is multidisciplinary and is designed primarily to save life and preserve vision.

Address: Department of Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, 450 Brookline Avenue, D3-133, Boston, MA 02215, USA. Electronic address: [email protected].; Department of Radiology, Boston Children's Hospital, Harvard Medical School, 300 Longwood Avenue, Boston, MA 02215, USA.; Department of Ophthalmology, Boston Children's Hospital, Harvard Medical School, 300 Longwood Avenue, Boston, MA 02215, USA.

DOI: 10.1016/j.pcl.2014.09.014

Link outs

Free resources

Other Literature Sources:

https://www.lens.org/lens/search/patent/list?q=ref...

Miscellaneous:

https://assays.cancer.gov/CPTAC-898

Subscription / membership required

Full Text Sources:

MeSH Terms: Genes, Retinoblastoma, Humans, Mutation, Neoplasm Staging, Retinal Neoplasms, Retinoblastoma